Loading organizations...
Loading organizations...
High-tech company specializing in cerebrovascular disease treatment.
Qianglian Zhichuang has raised $14.0M across 1 funding round.
Qianglian Zhichuang has raised $14.0M in total across 1 funding round.
Qianglian Zhichuang has raised $14.0M in total across 1 funding round.
Qianglian Zhichuang's investors include Yantai Biopharmaceutical Mother Fund.
Qianglian Zhichuang has raised $14.0M across 1 funding round. Most recently, it raised $14.0M Series D in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 28, 2023 | $14.0M Series D | Yantai Biopharmaceutical Mother Fund |